Both the brain and microbiome of humans develop rapidly in the first years of life, 27 enabling extensive signaling between the gut and central nervous system (dubbed the 28 "microbiome-gut-brain axis"). While emerging evidence implicates gut microorganisms 29 and microbiota composition in cognitive outcomes and neurodevelopmental disorders 30 (e.g., autism), the role of the gut microbial metabolism on typical neurodevelopment has 31 not been explored in detail. We investigated the relationship of the microbiome with the 32 neuroanatomy and cognitive function of 310 healthy children and demonstrated that 33 differences in gut microbial taxa and gene functions, including genes for the metabolism 34 and synthesis of glutamate and GABA, are associated with the size of brain regions 35 important during development such as the cerebellum, and with overall cognitive 36 function. 37
Introduction 38
The first years of life are a unique and dynamic period of neurological and cognitive 39 development. Throughout childhood, a child's brain undergoes remarkable anatomical, 40 microstructural, organizational, and functional change. By age 5, a child's brain has reached 41 >85% of its adult size, has achieved near-adult levels of myelination, and the pattern of axonal 42 connections has been established (Silbereis et al., 2016) . This development is profoundly 43 affected by the child's environment and early life exposures (Fox et al., 2010) . The first years of 44 life also witness dramatic changes in the gut microbiome. The gut microbial community is 45 seeded at birth, and develops over the course of the first year from a low-diversity community 46 dominated by Firmicutes and Proteobacteria, to a more diverse, adult-like microbiome upon the 47 introduction of solid food. This microbial community development is also shaped by the 48 environment, with factors such as mode of delivery and diet (breast milk vs formula) known to The gut, the gut microbiome, and central nervous system are intricately linked through a 52 system known as the gut-microbiome-brain axis (Clarke et al., 2013) , and the differences in 53 microbial communities have been shown to associate with, and in some cases cause, changes 54 in neurocognitive development and the outcome of neurological disorders such as autism 55 (Flannery et al., 2020; Gao et al., 2019; Sharon et al., 2019) . However, the study of the 56 relationships between environmental exposures, neurocognitive development, and the gut 57 microbiome during neurotypical development remains in its infancy. This is the first study from 58 Here, we focused on the relationship of microbial metabolic potential in the structural 66 development of the brain and in neurocognition. In particular, we show that microbial taxa and 67 genes with neuroactive potential, specifically genes encoding enzymes for the metabolism of 68 glutamate and GABA, are associated with the size of important brain regions and in cognitive 69 function. Understanding the relationship of intestinal GABA and glutamate metabolism may be 70 particularly important to understanding the role of the gut microbiome in early childhood 71 cognitive development, as together, GABA and glutamate responses make up the main 72 cerebellar output neurons (Carletti & Rossi, 2008; Hoshino, 2006 
Results and Discussion

79
To examine the relationships between early childhood gut microbiome and 80 neurocognitive development, we collected stool samples from 251 pregnant women and 310 81 children enrolled in the RESONANCE study of child development. As an initial characterization 82 step, we used shotgun metagenomic sequencing to generate taxonomic and functional profiles 83 for each of our maternal and child fecal samples. Participant age was the greatest driver of both 84 taxonomic and functional diversity, as expected ( Figure 1b taxonomic (species) profiles vs age; younger children cluster away from older children, and are 105 lower in diversity. d, same as (c) using first PCo axis for functional profiles (UniRef90 accessory 106 genes) after removing gene families that were present in >90% of subjects in a given age group; 107 variation is driven by similar effects as for taxonomic profiles. e, Child age vs. normalized 108 cognitive function score; age-appropriate assessments achieve similar score distributions for 109 their age groups. 110 gene functions even when different species contribute those functions. However, this 113 interpretation may be complicated by the fact that as many as 50% of sequencing reads in 114 some samples are not mapped to any of the reference genes used, and are thus unclassified 115 ( Supplementary Figure 2b) . Interestingly, although children under 1 tended to have substantially 116 fewer species and, therefore, fewer total genes (Figure 1c Supplementary Table 1 ). Subject type (child or mother) accounted for a large 133 amount of variation (4-6% q < 0.001), but this effect dropped to 2% when children under 2 years 134 of age were excluded, suggesting that age, rather than subject type, is actually responsible for over 20% of variation in both taxonomic and functional profiles, but this effect also largely suggesting that the age effect is primarily driven by the enormous changes in the microbiome 139 over the first year. 140
Microbiome taxonomic and functional variation was also associated with moderate but 141 significant differences in several neurocognitive measures including age-appropriate measures 142 of cognitive ability ([2.04%, 2.08%], q < 0.01, N=263). We also found significant associations 143 between regional brain volumes and microbial taxonomic and functional variation, including the 144 Supplementary Table 2 ). Briefly, we calculated the Pearson 159 correlation between the relative abundance of all identified UniRef90 gene families with each 160 neurocognitive measure, then calculated the Mann-Whitney U statistic for each potentially several molecules known to be important in the developing brain were significantly associated 163 with overall cognitive function scores and the size of brain subregions. with cognition and brain structure 168 a, FSEA analysis for gene sets with neuroactive potential (see Methods); many gene sets with 169 neuroactive potential are associated with cognitive function and brain structure. Figure 2a , Supplementary Table 2 ), subcortical (q < 0.01), and limbic (q < 176 0.001) volume, and negatively associated with cerebellar volume (q < 0.01) and overall 177 cognitive function (q < 1e-5). Interestingly, GABA degradation genes were also positively 178 associated with the size of the subcortex and negatively associated with cognitive function (q < 179 0.05). This may be due to higher GABA synthesis selecting for the ability to catabolize this 180 molecule, making it difficult to assess how actual GABA concentrations in the gut are associated 181 with brain development. GABA synthesis genes that could be assigned to specific taxa were 182 found primarily in E. coli in children under 1 year old, and in several different Bacteroides 183 species in older children (Figure 2b ). GABA degradation in younger children was also seen 184 extensively in E. coli, but declines dramatically in abundance in older kids (Figure 2c) . 185
Unlike the metabolism of GABA, glutamate synthesis and degradation genes have an 186 inverse relationship with neurocognitive measures (Figure 2a , Supplementary Table 2 ). The 187 glutamate degradation gene set was negatively associated with cognitive function (q < 1e-4) 188 and cerebellar volume (q < 0.05) and positively associated with the size of the neocortex (q < 189 0.05), while glutamate synthesis was marginally negatively associated with overall cognitive 190 function and the size of the neocortex, while positively associated with the size of the 191 cerebellum (q < 0.05). However, it remains difficult to predict how gut concentrations of 192 glutamate might be related to microbial metabolism; while it might be intuitive to expect that 193 higher glutamate synthesis and lower glutamate degradation would lead to higher gut 194 concentrations of glutamate, it might also be the case that lower glutamate concentrations 195 select for microbes that can synthesize it and against those that break it down. Glutamate is 196 also far more prevalent in the diet and can be rapidly metabolized by gut epithelial cells, making 197 the relationship between gut concentrations and microbial metabolism even more complex 198 (Reeds et al., 2000) . Unsurprisingly, as glutamate is an essential amino acid, Glu synthesis This is the first look at an ongoing study of child neurocognitive and microbiome 202 development. Using cross-sectional data, we have shown that differences in gut microbial taxa 203 and genes are associated with the structural development of the brain and with cognitive 204 development. In addition, we have shown that particular microbial gene sets with neuroactive 205 potential are associated with neurocognitive development, thus perhaps playing a direct role in 206 the gut luminal exposure of children to neuroactive metabolites. Glutamate and GABA 207 metabolism are of particular interest, since these are critical molecules for signaling from the 208 cerebellum during early development and learning, and the cerebellum is on the first brain 209 structures to develop in the fetal brain (Leto et al., 2016; Silbereis et al., 2016) . 210
Neurodevelopmental disorders, such as autism spectrum disorder, have been associated with 211 an imbalance of the inhibitory/excitatory system regulated by glutamate and GABA, with recent 212 evidence suggesting an impaired conversion of glutamate to GABA in the disorder (Fatemi et 213 al., 2012) , and understanding these pathological outcomes will depend on a deeper 214 understanding of developmental exposures in neurotypically developing children. 215
This study is ongoing, and we are collecting additional clinical data such as resting state 216 functional brain imaging, participant genetic profiles, lead exposure, air quality data and 217 nutritional information to understand how the environment, microbiome, and biological 218 development interact to shape neurocognition. Future studies assessing gut metabolite pools 219 combined with MR spectroscopic methods to quantify concentrations of neurotransmitters such 220 as GABA and glutamate-glutamine in the brain, as well humanized mouse models and 221 longitudinal human data, will provide further insight into the interactions of microbial metabolism 222 and neurocognitive development. As we continue to follow these subjects, we will be able to 
